Collected metastatic samples from pleura, pleural fluid, and liver were common in patients with EGFR mutant NSCLC, while metastatic samples from lymph nodes, adrenal gland, and brain were common in patients with other mutations (Figure 3B). Here, EGFR is linked to non-small cell lung carcinoma.